Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-1.
Gormez S, Gumusel HK, Ekicibasi E, Degirmencioglu A, Paudel A, Akan G, Atalar F, Erdim R, Eroglu E, Dagdelen S, Sariguzel N, Kirisoglu CE, Pamukcu B.
Gormez S, et al. Among authors: atalar f.
Bratisl Lek Listy. 2021;122(8):582-589. doi: 10.4149/BLL_2021_093.
Bratisl Lek Listy. 2021.
PMID: 34282625